Identification and functional perspective of a novel HLA-A allele: A*0279

Immunogenetics

Volumn 58, Issue 5-6, 2006, Pages 339-346

  Liu, Fangfang ^a,b   Wang, Shan ^a   Ye, Yingjiang ^a   Zhang, Huagang ^b   Zhang, Yu ^b   Chen, Weifeng ^b  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Crystal structure; Cytotoxic T lymphocytes; Elispot assay; HLA A supertype

Indexed keywords

GAMMA INTERFERON; HLA A ANTIGEN; ISOLEUCINE; THREONINE;

ADULT; ALLELE; ALPHA HELIX; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CELL STRAIN COS7; CONTROLLED STUDY; CRYSTAL STRUCTURE; CYTOTOXIC T LYMPHOCYTE; DIAGNOSTIC KIT; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HLA SYSTEM; HUMAN; HUMAN CELL; HYDROGEN BOND; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION SEQUENCE BASED TYPING; POLYMERASE CHAIN REACTION SINGLE SEQUENCE PRIMER; PRIORITY JOURNAL;

ADULT; ALLELES; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; CELLS, CULTURED; CROSS-PRIMING; CRYSTALLOGRAPHY; FEMALE; HLA-A ANTIGENS; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, SECONDARY; T-LYMPHOCYTES; VACCINES, SUBUNIT;

EID: 33744803232     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00251-006-0087-4     Document Type: Article

References (29)

1. Barouch D, Friede T, Stevanovic S, Tussey L, Smith K, Rowland-Jones S, Braud V, McMichael A, Rammensee HG (1995) HLA-A2 subtypes are functionally distinct in peptide binding and presentation. J Exp Med 182:1847-1856
2. Bertoni R, Sidney J, Fowler P, Chesnut RW, Chisari FV, Sette A (1997) Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J Clin Invest 100:503-513
3. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC (1987) Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329:506-512
4. Browning M, Krausa P (1996) Genetic diversity of HLA-A2: evolutionary and functional significance. Immunol Today 17:165-170
5. Brusic V, Petrovsky N, Zhang G, Bajic VB (2002) Prediction of promiscuous peptides that bind HLA class I molecules. Immunol Cell Biol 80:280-285
6. Chicz RM, Urban RG, Gorga JC, Vignali DA, Lane WS, Strominger JL (1993) Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med 178:27-47
7. Del Guercio MF, Sidney J, Hermanson G, Perez C, Grey HM, Kubo RT, Sette A (1995) Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J Immunol 154:685-693
8. Fleischhauer K, Tanzarella S, Russo V, Sensi ML, van der Bruggen P, Bordignon C, Traversari C (1997) Functional heterogeneity of HLA-A*02 subtypes revealed by presentation of a MAGE-3-encoded peptide to cytotoxic T cell clones. J Immunol 159:2513-2521
9. Gianfrani C, Oseroff C, Sidney J, Chesnut RW, Sette A (2000) Human memory CTL response specific for influenza a virus is broad and multispecific. Hum Immunol 61:438-452
10. Guo YJ (2002) Influenza activity in China: 1998-1999. Vaccine 15:S28-S35
11. Henderson RA, Michel H, Sakaguchi K, Shabanowitz J, Appella E, Hunt DF, Engelhard VH (1992) HLAA2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science 255:1264-1266
12. Khanna R, Burrows SR, Nicholls J, Poulsen LM (1998) Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA-A2 supertype-restricted immune recognition of EBV-infected cells by LMPIspecific cytotoxic T lymphocytes. Eur J Immunol 28:451-458
13. Livingston BD, Crimi C, Fikes J, Chesnut RW, Sidney J, Sette A (1999) Immunization with the HBV core 18-27 epitope elicits CTL responses in humans expressing different HLA-A2 supertype molecules. Hum Immunol 60:1013-1017
14. Madden DR (1995) The three-dimensional structure of peptide-MHC complexes. Annu Rev Immunol 13:587-622
15. Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI (2002) Nomenclature for factors of the HLA system. Hum Immunol 63:1213-1268
16. Matsui M, Hioe CE, Frelinger JA (1993) Role of the peptide-binding pockets of the HLA-A2 molecule in allorecognition by human cytotoxic T-cell clones. Proc Natl Acad Sci U S A 90:674-678
17. Matsui M, Moots RJ, Warburton RJ, Peace-Brewer AL, Tussey LG, Quinn DG, McMichael AJ, Frelinger JA (1995) Genetic evidence for difference between intracellular and extracellular peptides in influenza a matrix peptide-specific CTL recognition. J Immunol 154:1088-1096
18. McMichael AJ, Gotch FM, Santos-Aguado J, Strominger JL (1988) Effect of mutations and variations of HLA-A2 on recognition of a virus peptide epitope by cytotoxic T lymphocytes. Proc Natl Acad Sci U S A 85:9194-9198
19. Rivoltini L, Loftus DJ, Barracchini K, Arienti F, Mazzocchi A, Biddison WE, Salgaller ML, Appella E, Parmiani G, Marincola FM (1996) Binding and presentation of peptides derived from melanoma antigens MART-1 and glycoprotein-100 by HLA-A2 subtypes: implications for peptide-based immunotherapy. J Immunol 156:3882-3891
20. Santos-Aguado J, Crimmins MA, Mentzer SJ, Burakoff SJ, Strominger JL (1989) Alloreactivity studied with mutants of HLA-A2. Proc Natl Acad Sci U S A 86:8926-8940
21. Sette A, Sidney J (1998) HLA supertypes and supermotifs: a functional perspective on HLA polymorphism. Curr Opin Immunol 10:478-482
22. Sette A, Sidney J (1999) Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 50:201-212
23. Sette A, Vitiello A, Reherman B, Fowler P, Nayersina R, Kast WM, Melief CJ, Oseroff C, Yuan L, Ruppert J (1994) The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol 153:5586-5592
24. Sidney J, Grey HM, Southwood S, Celis E, Wentworth PA, Del Guercio MF, Kubo RT, Chesnut RW, Sette A (1996) Practical, biochemical and evolutionary implication of the discovery of HLA class I supermotifs. Immunol Today 17:261-266
25. Sidney J, Southwood S, Mann DL, Fernandez-Vina MA, Newman MJ, Sette A (2001) Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. Hum Immunol 62:1200-1216
26. Tussey LG, Matsui M, Rowland-Jones S, Warburton R, Frelinger JA, McMichael A (1994) Analysis of mutant HLA-A2 molecules. J Immunol 152:1213-1221
27. Utz U, Koenig S, Coligan JE, Biddison WE (1992) Presentation of three different viral peptides, HTLV-1 TAX, HCMV gB, and influenza virus M1, is determined by common structural features of the HLA-A2.1 molecule. J Immunol 149:214-221
28. Van der Burg SH, Visseren MJ, Brandt RM, Kast WM, Melief CJ (1996) Immunogenicity of peptide bound to MHC class I molecules depends on the MHC-peptide complex stability. J Immunol 156:3308-3314
29. Zhang HG, Pang XW, Shang XY, Xing Q, Chen WF (2003) Functional supertype of HLA-A2 in the presentation of Flu matrix p58-66 to induce CD8+ T-cell response in a Northern Chinese population. Tissue Antigens 62:285-229